findmyKOL

Alan Zajarias, MD

Enriched profile

Professor of Medicine · Washington University School of Medicine

ORCIDNPI
Region🇺🇸 Saint Louis, MO · Midwest · United StatesSpecialtyInterventional CardiologyFocusHeart Failure
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Alan Zajarias is Professor of Medicine at Washington University School of Medicine. OpenAlex indexes 188 publications with 14,832 citations (h-index 41); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Alan Zajarias, MD, is Professor of Medicine at Washington University School of Medicine, Cardiovascular Division, John T. Milliken Department of Medicine. The public record shows 188 publications with 14,832 citations (h-index 41), centered on Heart Failure. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 23 companies.

  • Most recent indexed publication: 2026 · Circulation. Cardiovascular interventions
  • Top research focus: Heart Failure
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 23 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure1 trialMitral Valve Insufficiency1 trialAortic Valve Stenosis1 trialConstriction, Pathologic1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure

Drugs & molecules

across trials, industry payments and publications
Verquvogeneric · VericiguatClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Medtronic, Inc.Clinical trialsIndustry payments112Edwards Lifesciences CorporationClinical trialsIndustry payments92Abbott LaboratoriesClinical trialsIndustry payments49

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
188publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

14,832citations

Total citations across indexed works.

41h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
23companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75%
    Beta blocker17.7%
    Metoprolol Succinate54%Carvedilol34%Metoprolol Tartrate9%Atenolol3%
    Part D<11 patients
    Statin13.1%
    Atorvastatin Calcium52%Rosuvastatin Calcium42%Pravastatin Sodium6%
    Part D<11 patients
  • Blood & clotting

    13.8%
    Factor Xa inhibitor6.9%
    Eliquis93%Xarelto7%
    Part D<11 patients
    P2Y12 inhibitor3.7%
    Clopidogrel100%
    Part D33 patients
  • Metabolism & gastrointestinal

    9.4%
    SGLT2 inhibitor4.9%
    Farxiga50%Jardiance50%
    Part D19 patients
    Potassium supplement3.7%
    Potassium Chloride83%Klor-Con M2017%
    Part D<11 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)49.7% facility · 50.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/alan-zajarias-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/Alan-Zajarias

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • LinkedIn

    linkedin.com/in/alan-zajarias-06786a18

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Universidad Nacional Autónoma de México

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bjc.org
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acc.org
  • Board Certified

    Cardiovascular Disease

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.wustl.edu
  • Board Certified

    Interventional Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.wustl.edu
  • Board Certified

    Echocardiography

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.wustl.edu
  • Board Certified

    Internal Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bjc.org

Editorial & leadership roles

journal and society appointments
  • Director

    Structural Heart Disease Program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.wustl.edu
  • Director

    Interventional and Structural Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.wustl.edu
  • Director

    Structural Heart Fellowship

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.wustl.edu
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
3 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Barnes-Jewish Hospital

    St. Louis, MO (clinical practice site / Heart Care Institute)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bjc.org

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.